Mölnlycke, a medical device company, has reportedly unveiled an innovative surgical glove, Biogel® PI UltraTouch® S.

Biogel® PI UltraTouch® S will help address the rising incidences of allergic contact dermatitis among the surgical teams, as they grapple with frequent exposure to chemicals and handwashing. As per reliable statistics, nearly 1/3rd of the nurses and surgeons suffered a skin reaction in the OR (operating room). The new product is the latest addition to Biogel, an industry-leading product line, which has been designed with a skin-friendly formula to lower allergic contact dermatitis risks. In addition, it is the 1st surgical glove to be approved by the U.S. FDA.

Biogel PI UltraTouch S has been developed without the addition of chemical accelerators that can cause allergic contact dermatitis. The product offers the same precision, perforation detection, and tactile sensitivity as other highly trusted Biogel products by healthcare professionals.

In 2020, SERMO had conducted a Mölnlycke-commissioned survey and revealed a high level of irritant & allergic contact dermatitis among nurses and surgeons in the U.S. healthcare system. For example, 31% of the surgeons & nurses in the OR suffered from skin reactions.

Several instances of Type IV allergic contact dermatitis have placed the nurses and surgeons at considerable risk. Moreover, it poses severe burdens on healthcare systems and hospitals due to occupational treatment costs and low productivity. In order to ensure an efficient, safe, and effective OR, dermatologically appropriate PPE (personal protective equipment) must be provided to these surgeons and the teams.

Mölnlycke Health Care’s VP of Surgical Marketing, Jeanne Marie Leahy, has reportedly stated that Biogel® PI UltraTouch® S will ensure protection as well as support the precision in the OR. With the help of the new product, the surgical team members who suffer from allergic contact dermatitis will achieve the same fit, safety, and precision offered by other Biogel gloves. The glove is currently available for hospitals in the United States.

Source credit: